baber/WOPTO huggingface dataset:
Patent FI-923106-A0 (FI)
Inventor: INOUE FUJIO
IPC: B65D30/22
Filed: 1992-07-06
Abstract: A multi-chamber vessel used mainly in the medical field, in which the flexible plastic vessel proper is divided into a plurality of chambers with partitioning means permitting communication as required, at least one of a plurality of chambers composing the vessel proper is not provided with a cover whereas at least one other chamber is provided with a cover which covers this chamber through a sealed space and is composed of a flexible film having water- and gas-barrier functions, and at least any of desiccant and deoxidizer is contained in said sealed space, whereby the vessel is low in price, excellent in quality and performance, and, further, easy to discard. <IMAGE>
Patent FI-930626-A0 (FI)
Inventor: ROSENBLUM MICHAEL
IPC: C07K14/00
Filed: 1993-02-12
Abstract: This invention relates to substantially purified gelonin, toxic fragments thereof, the DNA sequences encoding gelonin and use of the DNA for producing, by recombinant technology, gelonin, toxic fragments thereof and fusion proteins. More specifically, the invention relates to the primary amino acid sequence of gelonin, and of the DNA encoding said gelonin and the production of synthetic gelonin and toxic fragments thereof.
Patent FI-950764-A0 (FI)
Inventor: RAMAKRISHNAN KASTOORIRANGANATH
IPC: C07D495/04
Filed: 1995-02-20
Abstract: A unique class of chemiluminescent labels containing biotin substitution that are suitable for chemiluminescent assays using inter alia a streptavidin and/or avidin conjugate. The chemiluminescent labels of the invention have the ability to bind to streptavidin and/or avidin per se or to streptavidin and/or avidin conjugated with an analyte. Label structures are disclosed that have hydrolytic stability to meet the most demanding commercial assay conditions. The invention encompasses conjugates containing associated versions of the labeling compounds, assays and kits for performing such assay utilizing the conjugates.
Patent FI-991016-A0 (FI)
Inventor: SIRVIOE REIJO ANTERO
IPC: F16K5/06
Filed: 1999-05-04
Abstract: The invention relates to a ball seal for a ball valve. The ball valve comprises a valve chamber (5), which is closed by welding and contains a turnable valve ball (2), an inlet and outlet channel (4b) for the fluid, as well as in the valve ball, a flow passage channel (4a) for the fluid. Between the valve chamber and the valve ball, around the inlet and/or outlet channel (4b), there is placed a dual seal (1) comprising a support ring (7) made of some elastic material and provided with a peripheral surface (13a) directly supported against the stop surfaces (18a, resp. 18b) of the counterpart, and a bottom surface (13b), as well as an annular shoulder (14) pointing towards the valve ball, and a mainly V-shaped sealing ring (8) made of some resilient material, a first branch (9a) of said sealing ring being resilient along the length of the support ring, and a second branch (9b) being supported against the counterparts (3) of the valve chamber. <IMAGE>
Patent IL-83215-A0 (IL)
Title: Synthesis of bycyclic aromatic sulfonyl chlorides
IPC: C07D317/62
Filed: 1987-07-16
Abstract: A process for preparing bicyclic aromatic sulfonyl chlorides of the formula <CHEM>  wherein, n is 1 or 2;  A is -O- or -CH2-; and  B is -O-, -CH2-, or -NCH3-;  provided at least one of A or B is -O-,  which comprises reacting a compound of the formula <CHEM>  with a Villsmeier reagent of the formula <CHEM>   The bicyclic aromatic sulfonyl chlorides produced by the process can be used to prepare pharmaceutically useful sulfonylureas.
Patent IL-91056-A0 (IL)
Title: Amides of n15 alkyl and n15,n15-dialkyl teicoplanin derivatives
IPC: C07K1/02
Filed: 1989-07-20
Abstract: The present invention is directed to new N<6><3> amides of N<1><5>-alkyl and N<1><5>,N<1><5>-dialkyl derivatives of teicoplanin antibiotics and to a process for preparing them. The compounds of the invention show a good antibacterial activity mainly against gram-positive bacteria and allow an easy pharmaceutical formulation.
Patent IL-92994-A0 (IL)
Title: Pharmaceutical compositions comprising gemfibrozil
IPC: A61K9/22
Filed: 1990-01-08
Abstract: A disintegratable formulation of gemfibrozil providing both immediate and sustained release and comprises a tablet compressed from a mixture of a first and second granulation, and a disintegration excipient operable to effect partial or complete disintegration in the stomach. The first granulation comprises finely divided particles of pure gemfibrozil granulated with at least one cellulose derivative and the second granulation comprises finely divided particles of pure gemfibrozil granulated with a pharmaceutically acceptable water soluble or insoluble polymer which are then uniformly coated with a pharmaceutically acceptable (meth)acrylate copolymer prior to admixture with the first granulation. The first and second granulations are present in the final composition in a ratio of from about 10:1 to about 1:10.
Patent FI-20002630-A0 (FI)
Inventor: RAJAMAEKI TEUVO
IPC: D21F3/02
Filed: 2000-11-30
Abstract: A long nip press for machines transporting fibre webs, which press drains water from the fibre web and comprises two hydrostatic bearings opposite each other, both comprising a pressure shoe comprising a pressure chamber, the pressure shoe having a sealing element in the form of a flexible pressure-balancing diaphragm, and a press belt to press the fibre web against a fabric, the pressure-balancing diaphragm protruding on its edge-zone without support from the inner rim of the pressure shoe towards the pressure chamber. So as to make the long nip press very simple in structure and to enable self-adjusting, even and efficient lubrication in the nip, the protruding edge-zones comprise pinholes for transporting hydraulic fluid. The invention also relates to a pressure-balancing diaphragm.
Patent FI-20002845-A0 (FI)
Inventor: TIRKKONEN OLAV
IPC: H04L1/06
Filed: 2000-12-22
Abstract: An arrangement for coding digital symbols and transmitting them through at least two antennas. A coder reads at least two symbols belonging to the same transmission block and forms channel symbols of the symbols of the transmission block by means of a block code. The coder multiplies at least one symbol belonging to the transmission block by a first nonzero weighting coefficient and at least one symbol belonging to the transmission block by a second nonzero weighting coefficient, and the division ratio of the first and second weighting coefficients differs from values ±1, ±j and ±1/sqrt(2). The thus formed channel symbols are transmitted to the radio path through the antennas.
Patent FI-20010572-A0 (FI)
Inventor: HAEMAELAEINEN JOUNI
IPC: C10L10/02
Filed: 2001-03-21
Abstract: The invention relates to a method for sulphur retention in a power plant, in which, along with a fuel with a sulphur content and air, an additive is added to the firebox of a thermal boiler, which binds the sulphur dioxide arising in connection with combustion. According to the invention, the said additive is wood ash. <IMAGE>
Patent FI-20022040-A0 (FI)
Inventor: MUSTALAHTI JORMA
IPC: B66B19/02
Filed: 2002-11-15
Abstract: The invention also relates to a method for ensuring the internal tightness of an elevator hoisting rope (9) in an elevator provided with hoisting ropes (9). According to the method, each hoisting rope (9) is tightened after installation of the elevator to a desired tightness by twisting the rope by the required number of turns in the twisting direction of the braiding, in such manner that the first end of the rope (9) remains fastened to its anchorage while the second end of the rope is free so as to allow tightening.
Patent FI-20050139-A0 (FI)
Inventor: HEINER ANDREAS
IPC: H04L12/54
Filed: 2005-02-07
Abstract: A method distributes connection admission control. Traffic flows are distributed locally at network nodes based on determined path weights and dynamic link costs. A traffic source node is sent a back-off signal if a distributing node becomes congested. A received request to admit a new traffic flow to the communications network is admitted if the node receiving the request has not received a back-off signal, and is rejected if the node receiving the request has received a back-off signal and fails to redistribute its traffic flows. Distributed connection admission control is allowed in which only local events need to be monitored to decide whether to admit a new traffic flow or not.
Patent FI-20110326-A0 (FI)
Inventor: WEST FILIP
IPC: A01B/
Filed: 2011-09-26
Abstract: A control system for hydraulically operated tools connected to ordinary agricultural tractors, where a connecting unit releases some of the CAN bus units of the tractor from the control circuit of the tractor before the control unit of the tool takes over the control of these CAN bus units.
Patent IL-103667-A0 (IL)
Title: Manufacture of a composite product by moulding
IPC: B29B15/12
Filed: 1992-11-06
Abstract: Prod. comprises a thermoplastic organic material; e.g. polypropylene, polyamide or polyester; with fibre reinforcement eg. glass fibre; mineral and organic additives is made by moulding extrusion or injection from material supplied from an extruder where at least part of the organic material is fed in the form of strands or continuous filaments. The organic material and reinforcing fibres may be fed at the same or via two different feed entries, also the input may be a continuous filament which itself is a composite of reinforcement and organic material.
Patent IL-104305-A0 (IL)
Title: Piperazine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P25/20
Filed: 1993-01-05
Abstract: PCT No. PCT/GB92/02399 Sec. 371 Date Jul. 7, 1994 Sec. 102(e) Date Jul. 7, 1994 PCT Filed Dec. 24, 1992 PCT Pub. No. WO93/14076 PCT Pub. Date Jul. 22, 1993.    <IMAGE>  (I)  This invention concerns compounds of formula (I) where A is an alkylene chain of 2 to 5 carbon atoms optionally substituted by one or more lower alkyl groups, R represents hydrogen or one or two same or different lower alkyl groups, R1 is a monocyclic aryl or heteroaryl radical, R2 is a mono or bicyclic aryl radical and R3 is cycloalkyl. The compounds of the invention are useful as antidepressant, antianxiety, or hypotensive agents; or for regulating the sleep/wake cycle, feeding behavior and/or sexual function; and for treating cognition disorders.
Patent IL-107756-A0 (IL)
Title: Novel bacillus thuringiensis isolates active against lepidopteran pests
IPC: A01N63/23
Filed: 1993-11-25
Abstract: The invention relates to a Bacillus thuringiensis strain(s) which solely produces a CryIA(a) crystal delta-endotoxin having a molecular weight of 130,000 daltons and is active against lepidopteran pests. The invention is also related to a spore(s), mutant(s), or crystal delta-endotoxin obtainable therefrom. Furthermore, the invention relates to insecticidal compositions comprising the B.t. strain, spore, mutant or crystal delta-endotoxin of the present invention. The invention further relates to methods of using the insecticidal compositions to control an insect pest(s) of the order Lepidoptera.
Patent IL-114156-A0 (IL)
Title: Substituted azaindolylidene compounds process for their preparation pharmaceutical compositions containing them and their uses
IPC: A61K31/435
Filed: 1995-06-15
Abstract: PCT No. PCT/EP95/02043 Sec. 371 Date Feb. 9, 1996 Sec. 102(e) Date Feb. 9, 1996 PCT Filed May 30, 1995 PCT Pub. No. WO96/00226 PCT Pub. Date Jan. 4, 1996The present invention relates to compounds useful as tyrosine kinase inhibitors, having the following general formula (I)    <IMAGE>  (I)  wherein one of the groups X1, X2, X3, X4 is N and the others are CH; R is a group of formula (a), (b), (c) or (d)    <IMAGE>  (a)   <IMAGE>  (b)   <IMAGE>  (c)   <IMAGE>  (d)   each of R1 and R3 independently is hydrogen, amino, carboxy, cyano, -SO3R4, -SO2NHR5,   <IMAGE>    -COOR6, -CONH(CH2)oPh, -CONHCH2(CHOH)nCH2OH,   <IMAGE>    -N (CH2CH2OH)2, -NHCH2(CHOH)nCH2OH, -NHCONH2, -NHC(NH2)=NH, -NHCO(CHOH)nCH2OH,   <IMAGE>    -NHSO2R7, -OCH2(CHOH)nCH2OH, -OOC(CHOH)nCH2OH, -OPO(OH)2, -OCH2SO2NH2, -CH2NH2, -C(NH2)=NH, -CH2NHC(NH2)=NH,   <IMAGE>    -CH2OH, -CH2OOC(CHOH)nC2OH, -CH2OPO(OH)2, -PO(OH)2; R2 is H, C1-C6 alkyl, C2-C6 alkanoyl, -CH2OH, -CH2CH2CONH2, -SO2Me, -COCH2SO2NH2; R4 is H, -CH2(CHOH)nCH2OH, C1-C6 alkyl; R5 is H, C1-C6 alkyl, -CH2(CHOH)nCH2OH, -(CH2)mNMe2; R6 is C1-C6 alkyl, unsubstituted or substituted by phenyl, -CH2(CHOH)nCH2OH; R7 is Me, -C6H4Me; Z is CH2, O, NH, NCH2CH2OH; n is 1 or 1; m is 2 or 3; o is 0, 1, 2 or 3; p is 1, 2 or 3; provided that when R is (a), (b), or (c) then R1 is not H and when R is (d) then one of R1 and R3 is not H; and the pharmaceutically acceptable salts thereof.
Patent IL-115105-A0 (IL)
Title: Topical ketoconazole emulsions
IPC: A61K47/00
Filed: 1995-08-30
Abstract: PCT No. PCT/EP95/03366 Sec. 371 Date Feb. 24, 1997 Sec. 102(e) Date Feb. 24, 1997 PCT Filed Aug. 25, 1995 PCT Pub. No. WO96/06613 PCT Pub. Date Mar. 7, 1996The invention concerns stable emulsions comprising ketoconazole having a pH in the range from 6 to 8, characterized in that the emulsions lack sodium sulfite as an antioxidant; process of preparing said emulsions.
Patent IL-129292-A0 (IL)
Title: Fusogenic liposome composition and method
IPC: A61K9/127
Filed: 1997-10-10
Abstract: A fusogenic liposome composition for delivering a liposome-entrapped compound into the cytoplasm of a target cell is described. The liposomes have an outer surface coating of chemically releasable hydrophilic polymer chains which shield hydrophobic polymers on the liposome outer surface. Release of the hydrophilic polymer chains exposes the hydrophobic polymers for interaction with outer cell membranes of the target cells to promote fusion of the liposome with the target cells. Also disclosed is a method for using the composition to deliver a compound to target cells, and a method for selecting suitable hydrophobic polymers for use in the composition.
Patent IL-134597-A0 (IL)
Title: Therapy for staphylococcus aureus
IPC: C07K9/00
Filed: 1998-08-18
Abstract: The present invention is directed to methods for treating infections caused by Staphylococcus aureus with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of Staphylococcus aureus which are methicillin resistant, such as the Mu50 strain.
Patent IL-134980-A0 (IL)
Title: Medical needle safety apparatus and methods
IPC: A61M25/06
Filed: 1998-09-03
Abstract: Parts which may be integrally molded with a phlebotomy barrel or with a Luer fitting to provide, in a single molded part, an extendable safety enclosure for a medical cannula in phlebotomy, syringe and other general medical needle applications. Integrally molded part phlebotomy safety devices are disclosed which require only the integrally-molded part, a medical needle, a label and a transport needle cover to form a ready-to-use phlebotomy device. Upon removal of the label and needle cover, the device is ready for use in a medical procedure. The enclosure comprises a plurality of rigid segments serially connected by a plurality of intersegment hinges, which are preferably living hinges. The segments are disposed about a medical needle, folded upon each other during the medical procedure and extended at the end of the procedure to form a secure, substantially rigid safety shroud. During the procedure, the enclosure is folded and conveniently disposed about a proximal portion of the needle. At the end of the procedure, the enclosure is extended to protectively sheath and secure the needle in a substantially rigid structure formed in combination by the enclosure and the needle.
Patent IL-135077-A0 (IL)
Title: A probe for use in non-invasive measurements of blood related parameters
IPC: A61B5/022
Filed: 2000-03-15
Abstract: A probe device for use in non-invasive optical measurements of at least one parameter of the patient's blood. The probe device comprises a finger holder in the form of a clip member that secures a fingertip between its clamping legs. The probe device supports a measuring unit for applying optical measurements to a measurement location on the finger and carries a pressurizing assembly operable for applying controllably variable, substantially under-systolic pressure to the finger in the vicinity of the measurement location. Several measurement sessions are performed at the measurement location with at least two different wavelength of incident light to detect light response of the medium and generate measured data indicative thereof, and the pressure applied to the vicinity of the measurement location is simultaneously varied during measurements. The light response of the medium corresponding to different wavelength of the incident light and different pressure values during measurements. The light response of the medium corresponding to different wavelength of the incident light and different pressure values is analyzed, and an optimal pressure value is determined, so as to utilize the corresponding light response of the medium for deriving therefrom the at least on blood parameter.
Patent IL-141502-A0 (IL)
Title: Use of polyester resins for production of articles having good properties as barriers to water vapour
IPC: C08L67/04
Filed: 1999-08-27
Abstract: Polyester resins formed by recurring units X=[O-(CH2)n-OCO-(CH2)m-CO] and/or Y=[O-(CH2)k-CO], where the half-sum of n+m is equal to or greater than 6 and k is a number equal to or greater than 6, or by copolymers comprising units and/or sequences having the formula xi[O-(CH2)ni-OCO-(CH2)mi-CO]; yj[O-(CH2)kj-CO] where: i,j=1-5; ni=2-22; mi=0-20; kj=1=21; (Formula (1)) and xi and yj vary between 0 and 1 and are molar fractions of the various units such that (Formula (2)), are used for the preparation of products in which a permeability to water vapour of less than 350 gx30 mum/m<2 >per day, measured at 38° C. and 90% RH and good biodegradability are required.
Patent IL-156103-A0 (IL)
Title: Valve mechanism for infusion fluid systems
IPC: B01D61/24
Filed: 2001-12-07
Abstract: A method and an apparatus are provided for preventing retrograde flow of fluid, e.g., blood products, into a source of sterile substitution fluid ( 50 ). The apparatus of the present invention includes a controllable pinch valve member ( 110 ) that is placed on a section of a conduit ( 90 ) which carries sterile substitution fluid to an extracorporeal circuit ( 30 ). In one embodiment, control over the valve member ( 110 ) is based on a control unit ( 120 ) using fluid pressures that are sensed upstream and downstream of the valve member ( 110 ) by upstream sensor ( 121 ) and downstream pressure ( 122 ) respectively. The valve member ( 110 ) is preferably opened only when the upstream pressure is greater than the downstream pressure. This assures that the substitution fluid flows only in a single direction when the pinch valve member ( 110 ) completely occludes the conduit ( 90 ) when in a closed position. Therefor, blood will not contaminate the sterile fluid by being drawn into the conduit ( 90 ) due to pressure differences.
Patent IL-157946-A0 (IL)
Title: Combination therapy
IPC: C12N15/28
Filed: 2002-03-14
Abstract: The invention provides for the treatment of diseases or disorders characterized by cells expressing the CD40 membrane glycoprotein. The invention provides methods for the treatment of various diseases or disorders characterized by cells expressing CD40 with a combination of an agent causes the depletion of cells expressing CD40 and a second agent which causes the depletion of cells expressing the CD20 membrane antigen. Pharmaceutical compositions and articles of manufacture such as kits comprising the agents and combinations thereof are also provided.
Patent IL-159070-A0 (IL)
Title: Use of corrinoids in the treatment of skin diseases
IPC: A61P17/00
Filed: 2002-06-26
Abstract: The use of corrinoids (I) (i.e. vitamin B 1 2 or related cobalamin compounds) for developing and improving the resistance power of the skin is new. The use of corrinoids of formula (I) is claimed for building up and improving the resistance power of the skin. [Image] R : CN, OH, CH 3 or H 2O. ACTIVITY : Dermatological; Antiinflammatory; Immunosuppressive; Antipsoriatic; Antiseborrheic; Antiulcer; Antipruritic; Antiallergic; Antialopecia; Fungicide; Vulnerary; Cytostatic. MECHANISM OF ACTION : Skin resistance stimulant.
Patent IL-179865-A0 (IL)
Title: Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet a powder or a capsule and the process for its preparation
IPC: A61K9/48
Filed: 2006-12-05
Abstract: The present invention provides a new stable pharmaceutical composition containing 5-[[4-[3-Methyl-4-oxo-3,4-dihydro-2-quinazolinyl]methoxy]phenyl-methyl]thiadiazolidine-2,4-dione as active ingredient.
Patent IL-192283-A0 (IL)
Title: Lattice structure, use of the lattice structure and vessel with lattice structure
Filed: 2008-06-18
Abstract: Grid structure (1) comprises transversal bars (20) and/or longitudinal bars (10) having a rib arrangement (8) of ribs (31, 32) protruding vertical to the grid surface (6) on one side (2, 3) of the structure. A first group and a second group of ribs are provided and differ in height. An independent claim is also included for a container, especially a filter cartridge, with a water inlet window, a water outlet window and an air outlet window with the above grid structure.
Patent IL-206163-A0 (IL)
Title: Method and apparatus for continuous production of a textile structure resistant to perforation and penetration and textile structure thus obtained
Filed: 2010-06-03
Abstract: The present invention refers to a method for continuous production of a textile structure resistant to perforation and penetration, comprising the steps consisting in: 
a) simultaneously weaving two fabric elements overlapped and spaced from each other, wherein at least the warp or chain threads of the upper fabric element and the weft threads of the lower fabric element, or vice-versa, comprise ballistic threads; 
b) inserting, during said weaving step, at least one intermediate layer between said upper fabric element and 
said lower fabric element; 
c) joining the assembly of the two upper and lower fabric elements interposed between which is said intermediate layer to obtain a multilayer textile structure.
Patent ZM-987-A1 (ZM)
Title: New dihydrobenzofuran and chroman-carboxamide derivatives,processes for the preparation thereof and use thereof as neuroleptics
IPC: C07D311/04
Filed: 1987-01-29
Abstract: The invention relates to new dihydrobenzofuran- and chroman-carboxamide derivatives of the general formula:   <IMAGE> (I) in which R and R' are each hydrogen or methyl; n is 1 or 2; m is 1 or 2; Z is either   <IMAGE> (a)   wherein R1 and R2 are lower alkyl, or <IMAGE> (b)  wherein R3 is alkyl, alkenyl, cycloalkyl-alkyl, cycloalkenyl-alkyl, X is H, NH2, methoxy, or methyl and Y is H, Cl, cycloalkylmethylsulfonyl, alkylsulfamoyl or alkylsulfonyl and to their pharmacologically acceptable acid addition salts and their optical isomers, to the processes for the preparation thereof and to the use thereof as medicaments, especially as neuroleptics.
Patent IE-910120-A1 (IE)
Title: Improved screw and method of making same
Inventor: ROBERTS DAVID
IPC: E04D3/36
Filed: 1991-01-15
Abstract: A self-drilling self-tapping screw for use in fastening corrugated cladding to a support structure, is provided with a hole en larger 7 comprising axially extending ribs 8 for enlarging (e.g. by roaming) a hole already formed through the cladding by the drilling tip 3 of the screw. The hole enlarger 7 is positioned at or adjacent the junction between a threaded section 4 of the shank and a non-threaded section 5. The hole enlarger 7 ensures that the enlarged hole has a diameter no less than that of the non-threaded section 5 of the shank. The screw is formed by a method in which the thread is rolled, and the thread rolling die is modified so as to produce the hole enlarger 7 on the screw shank. The enlargement of the hole prevents damage to an anti-corrosion coating on the screw.